Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

van den Born

Showing results (41-50 of 768) with videos related to

Pageof 77
Sort By:
Current Opinion in Lipidology|December 17, 2020
Impact drugs targeting cardiometabolic risk on the gut microbiotaManon Balvers, Bert-Jan H van den Born, Evgeni Levin, et al.
Ophthalmic Paediatrics and Genetics|December 1, 1992
A retrospective study of registered retinitis pigmentosa patients in The NetherlandsL I van den Born, A A Bergen, E M Bleeker-Wagemakers
Evidence-Based Cardiovascular Medicine|March 15, 2006
Beta-blockers may be less effective than other antihypertensivesBert-Jan H van den Born, Gert A van Montfrans, Debbie Singh
Journal of Clinical Hypertension (Greenwich, Conn.)|May 21, 2020
Hypertension control in sub-Saharan Africa: Clinical inertia is another elephant in the roomEva L van der Linden, Charles Agyemang, Bert-Jan H van den Born
Journal of Virology|April 29, 2005
Discontinuous subgenomic RNA synthesis in arteriviruses is guided by an RNA hairpin structure located in the genomic leader regionErwin van den Born, Clara C Posthuma, Alexander P Gultyaev, et al.
The EMBO Journal|December 18, 2001
Sequence requirements for RNA strand transfer during nidovirus discontinuous subgenomic RNA synthesisA O Pasternak, E van den Born, W J Spaan, et al.
American Journal of Hypertension|August 7, 2007
The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertensionBert-Jan H van den Born, Richard P Koopmans, Gert A van Montfrans
Lancet (London, England)|August 10, 2010
Prognostic significance of blood-pressure variabilityBas van den Bogaard, Berend E Westerhof, Bert-Jan H van den Born
Frontiers in Bioscience (Landmark Edition)|June 2, 2009
Heparan sulfate proteoglycans in extravasation: assisting leukocyte guidanceJohanna W A M Celie, Robert H J Beelen, Jacob van den Born
Protein Science : a Publication of the Protein Society|April 1, 1995
Theoretical analysis of the structure of the peptide fasciculin and its docking to acetylcholinesteraseH K van den Born, Z Radić, P Marchot, et al.
Pageof 77

Showing results (41-50 of 768) with videos related to

Sort By:
Pageof 77
Current Opinion in Lipidology|December 17, 2020
Impact drugs targeting cardiometabolic risk on the gut microbiotaManon Balvers, Bert-Jan H van den Born, Evgeni Levin, et al.
Ophthalmic Paediatrics and Genetics|December 1, 1992
A retrospective study of registered retinitis pigmentosa patients in The NetherlandsL I van den Born, A A Bergen, E M Bleeker-Wagemakers
Evidence-Based Cardiovascular Medicine|March 15, 2006
Beta-blockers may be less effective than other antihypertensivesBert-Jan H van den Born, Gert A van Montfrans, Debbie Singh
Journal of Clinical Hypertension (Greenwich, Conn.)|May 21, 2020
Hypertension control in sub-Saharan Africa: Clinical inertia is another elephant in the roomEva L van der Linden, Charles Agyemang, Bert-Jan H van den Born
Journal of Virology|April 29, 2005
Discontinuous subgenomic RNA synthesis in arteriviruses is guided by an RNA hairpin structure located in the genomic leader regionErwin van den Born, Clara C Posthuma, Alexander P Gultyaev, et al.
The EMBO Journal|December 18, 2001
Sequence requirements for RNA strand transfer during nidovirus discontinuous subgenomic RNA synthesisA O Pasternak, E van den Born, W J Spaan, et al.
American Journal of Hypertension|August 7, 2007
The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertensionBert-Jan H van den Born, Richard P Koopmans, Gert A van Montfrans
Lancet (London, England)|August 10, 2010
Prognostic significance of blood-pressure variabilityBas van den Bogaard, Berend E Westerhof, Bert-Jan H van den Born
Frontiers in Bioscience (Landmark Edition)|June 2, 2009
Heparan sulfate proteoglycans in extravasation: assisting leukocyte guidanceJohanna W A M Celie, Robert H J Beelen, Jacob van den Born
Protein Science : a Publication of the Protein Society|April 1, 1995
Theoretical analysis of the structure of the peptide fasciculin and its docking to acetylcholinesteraseH K van den Born, Z Radić, P Marchot, et al.
Pageof 77